In 2019, CliniSys | MIPS launched its Genetics LIS, with a successful phase of development and deployment in Europe. Now, it has launched a clinical counterpart to the system. Stéphane Decap and Emma Huntridge outline the benefits of GLIMS Genetics Counselling to clinicians, laboratories, patients and their families.
We explain how regional diagnostics hubs that give clinicians access to test results of all kinds, no matter where they are carried out, could help the NHS to address some of the big challenges facing it – while improving services for patients.
CliniSys is leaving its old office in Sauchiehall Street and moving around the corner to Bothwell Street. Chief executive Richard Craven reflects on a bittersweet moment; one that closes a chapter on the company’s 30-year history in Scotland, while opening a new one for the long-term.
New identity for CliniSys and MIPS is launched with refreshed logo and updated website Move reflects 40-year history of delivering industry-leading, end-to-end solutions for customers paired with a commitment to future innovation.
In its simplest form at CliniSys, it is about ‘joining the dots’ and bringing the organisation together as one powerful brand and voice. Marketing planning is already underway and starting in the first quarter of 2021 there will be a series of initiatives to support the CliniSys Group’s marketing and corporate goals.
CliniSys has launched a new laboratory information management system for genomic laboratories in the UK. The company has brought GLIMS Genomics to the UK from Europe, where it is being successfully deployed at Poitiers University Hospital in France and will be introduced into seven additional laboratories in coming months.
Barts Health NHS Trust had a mixed estate of LIMS across its sites. The Trust identified that management of multiple systems and hardware platforms was far from optimal, and the migration to a single platform across all sites would improve efficiency and workflow, and would enable all sites to benefit from enhanced WinPath Enterprise functionality.
We consider how the tumultuous events of 2020 will impact on 2021, and how they will affect the company, the NHS, and the world of pathology for years to come.
We reflect on some of the profound changes that the novel coronavirus has brought to CliniSys, to healthcare, and to pathology, and how they are likely to play out in a post-Covid future.
What can the mobilising genomics laboratory hubs learn from the more advanced pathology networks? CliniSys marketing manager Matthew Fouracre put the question to programme manager Tony Oliver and genomics consultant Steve Abbs, who agreed the first lesson would be: implement a single laboratory information system to drive standardisation.
